文献速递妇科

胚系BRCA变异、生活方式与卵巢癌生存

Germline BRCA variants, lifestyle and ovarian cancer survival.
PubMed 文献 · Gynecol Oncol · 2022-04-07

在澳大利亚两个浸润性上皮性卵巢癌队列(合计n=1923)中,体力活动、BMI或酒精摄入与生存关联甚微且按BRCA状态无差异;诊断前当前吸烟与更差生存的关联在BRCA变异携带者(HR 1.98;95%CI 1.20-3.27)中强于非携带者(HR 1.18;95%CI 0.96-1.46;交互作用p=0.02)。合并美国与英国两个额外队列(n=2120)后,四研究汇总显示携带者当前吸烟汇总HR为1.94(95%CI 1.28-2.94),非携带者为1.08(95%CI 0.90-1.29)。

要点

  • 诊断前当前吸烟与更差生存的关联在BRCA变异携带者中强于非携带者,交互作用p=0.02。
  • 体力活动、BMI或酒精摄入与生存关联甚微,且按BRCA状态无差异。
  • 四研究汇总当前吸烟HR:携带者1.94(95%CI 1.28-2.94)vs 非携带者1.08(95%CI 0.90-1.29)。

核心结论

  • 结果提示吸烟对生存的不良影响在BRCA变异女性中可能强于无BRCA变异者。
  • 因此,戒烟可能改善所有卵巢癌女性的结局,但对BRCA变异携带者可能带来更大获益。

研究设计与样本

  • 在澳大利亚两个浸润性上皮性卵巢癌女性队列中调查诊断前生活方式指标,采用Cox比例风险回归计算校正风险比(HR)及95%置信区间(CI)。
  • 合并研究合计n=1923。
  • 另合并来自美国和英国的两个额外队列(n=2120)进行汇总分析。

主要发现

  • 在合并研究(n=1923)中,体力活动、BMI或酒精摄入与生存关联甚微,且按BRCA状态无差异。
  • 诊断前当前吸烟与更差生存的关联在BRCA变异携带者(HR 1.98;95%CI 1.20-3.27)中强于非携带者(HR 1.18;95%CI 0.96-1.46;交互作用p=0.02)。
  • 合并美国与英国两个额外队列(n=2120)后观察到吸烟的类似差异关联。
  • 四研究合并结果显示,当前吸烟在BRCA变异携带者中的汇总HR为1.94(95%CI 1.28-2.94),非携带者为1.08(95%CI 0.90-1.29)。

临床怎么用

  • 作者认为,戒烟可能改善所有卵巢癌女性的结局,但对BRCA变异携带者可能带来更大获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Women with ovarian cancer who have a pathogenic germline variant in BRCA1 or BRCA2 (BRCA) have been shown to have better 5-year survival after diagnosis than women who are BRCA-wildtype (non-carriers). Modifiable lifestyle factors, including smoking, physical activity and body mass index (BMI) have previously been associated with ovarian cancer survival; however, it is unknown whether these associations differ by germline BRCA status. METHODS: We investigated measures of lifestyle prior to diagnosis in two cohorts of Australian women with invasive epithelial ovarian cancer, using Cox proportional hazards regression to calculate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: In the combined studies (n = 1923), there was little association between physical activity, BMI or alcohol intake and survival, and no difference by BRCA status. However, the association between current smoking status before diagnosis and poorer survival was stronger for BRCA variant carriers (HR 1.98; 95% CI 1.20-3.27) than non-carriers (HR 1.18; 95% CI 0.96-1.46; p-interaction 0.02). We saw a similar differential association with smoking when we pooled results from two additional cohorts from the USA and UK (n = 2120). Combining the results from all four studies gave a pooled-HR of 1.94 (95% CI 1.28-2.94) for current smoking among BRCA variant carriers compared to 1.08 (0.90-1.29) for non-carriers. CONCLUSIONS: Our results suggest that the adverse effect of smoking on survival may be stronger for women with a BRCA variant than those without. Thus, while smoking cessation may improve outcomes for all women with ovarian cancer, it might provide a greater benefit for BRCA variant carriers.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gersekowski K, Delahunty R, Alsop K, et al. Germline BRCA variants, lifestyle and ovarian cancer survival. Gynecol Oncol. 2022. PMID: 35400525. doi:10.1016/j.ygyno.2022.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。